Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Infection01:20

Infection

11.6K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.6K
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

524
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
524
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

676
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
676
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

2.5K
The pathophysiology of pneumonia involves the following steps:
2.5K
Stages of Infection01:26

Stages of Infection

64.7K
Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
64.7K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

2.6K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DNA damage-associated vesicle production in <i>Stenotrophomonas maltophilia</i> is mediated by the maltocin endolysin.

Journal of bacteriology·2026
Same author

Optimizing macrophage-targeted intracellular delivery systems for safe and effective immunotherapies.

Advanced drug delivery reviews·2026
Same author

Small intestinal organoids as a model to study interactions of <i>C. suis</i> with its porcine host.

Frontiers in microbiology·2026
Same author

Predicting Agitation Stability of Monoclonal Antibodies during Developability Assessment.

Molecular pharmaceutics·2026
Same author

Cationic mRNA Lipid Nanoparticles for Ex Vivo NanoCAR-T Cell Engineering.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

A Nanobody-Based Toolbox to Probe ApoE4 in the Secretory Pathway and Cytosol.

Cells·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
See all related articles

Related Experiment Video

Updated: Jan 8, 2026

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses
09:07

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses

Published on: June 14, 2020

11.5K

Basic Science and Pathogenesis.

Laure Vandevelde1, Olivier Zwaenepoel1, Kevin Braeckmans1

  • 1Ghent University, Ghent, Oost-Vlaanderen, Belgium.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|December 24, 2025
PubMed
Summary
This summary is machine-generated.

Researchers developed anti-apoE4 nanobodies to study Alzheimer's disease (AD) risk. These nanobodies target apolipoprotein E4 (apoE4) in human neurons, offering a new tool to understand AD pathogenesis.

More Related Videos

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia
13:45

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia

Published on: September 21, 2019

6.0K
Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses
08:38

Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses

Published on: February 22, 2019

6.3K

Related Experiment Videos

Last Updated: Jan 8, 2026

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses
09:07

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses

Published on: June 14, 2020

11.5K
A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia
13:45

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia

Published on: September 21, 2019

6.0K
Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses
08:38

Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses

Published on: February 22, 2019

6.3K

Area of Science:

  • Neuroscience
  • Genetics
  • Biotechnology

Background:

  • The APOE-ε4 allele is the primary genetic risk factor for Alzheimer's disease (AD), but its precise role in AD pathogenesis remains unclear.
  • Apolipoprotein E4 (apoE4), encoded by APOE-ε4, is implicated in AD, necessitating tools to study its cellular functions.
  • Nanobodies present a novel approach for intracellular targeting and studying the pathological effects of apoE4 in AD models.

Purpose of the Study:

  • To develop and characterize novel nanobodies that specifically target the apoE4 isoform of apolipoprotein E.
  • To utilize these anti-apoE4 nanobodies as intrabodies within induced pluripotent stem cell (iPSC)-derived neurons to model AD pathogenesis.
  • To investigate the impact of apoE4 on amyloid beta 1-42 and phospho-tau levels in human neurons and assess the therapeutic potential of nanobody-mediated apoE4 degradation.

Main Methods:

  • Immunization of a llama with apoE4 to generate a repertoire of nanobodies.
  • Characterization of nanobodies using immunoprecipitation assays for specificity against apoE4, apoE3, and their termini.
  • Co-transfection of nanobodies and apoE4 in HEK293T cells to assess intracellular functionality and colocalization.
  • Differentiation of apoE4 and apoE3 homozygous iPSC lines into neurons for comparative analysis of AD biomarkers.
  • Delivery of engineered nanobodies with degradation tags into neurons via laser-induced photoporation to induce apoE4 degradation.

Main Results:

  • A panel of specific anti-apoE4 nanobodies was successfully generated and characterized.
  • Functional intrabodies capable of targeting intracellular apoE4 were identified.
  • An in vitro human cell model using iPSC-derived neurons from apoE4 carriers was established for AD studies.
  • Elevated levels of amyloid beta 1-42 and phospho-tau are anticipated in apoE4 neurons compared to apoE3 neurons.
  • The degradation of apoE4 using targeted nanobodies is expected to modulate AD-related protein levels.

Conclusions:

  • Nanobodies are effective tools for intracellularly targeting and manipulating apoE4.
  • This approach provides a powerful platform for investigating apoE4's role in Alzheimer's disease pathogenesis.
  • Further studies can explore the therapeutic implications of nanobody-mediated apoE4 reduction in AD.